Nanotech Security’s Optical Nanotechnology Receives Pre-Commercial Technology Award

Nanotech Security Corp. (the “Company”), developer of next-generation security and authentication features using patented nano-optics, is pleased to announce that it has received a Technology Impact Award (TIA) for Most Promising Pre-Commercial Technology at the annual British Columbia Technology Industry Association awards ceremony.

The award recognizes the outstanding achievement for a technological advancement that has high potential to commercialize within five years.

Nanotech Security CEO, Doug Blakeway commented ”Our optical nanotechnology exploits a similar phenomenon found on the iridescent wings of the Morpho butterfly, which have a grid of tens of millions of nano-scale (billionth of a meter) markings that trap, intensify and reflect light in a way that causes the wings to scintillate brilliant colours. At Nanotech Security we have developed a patented technology that improves on nature by directly embossing nanometer-scale indentations onto various materials using algorithms which increase hole density by a factor of ten creating true recognizable pure colour images which can even be animated. The potential for enhanced anti-counterfeiting and other commercial applications are far beyond any existing image-based technologies such as holograms.”

Mr Blakeway added ”We appreciate the recognition of the BC Technology Industry Association whose membership and resources are a constant source of support and inspiration for us. The association makes an important contribution to the economic well-being of all British Columbians.”

On Behalf of the Board of Directors of Nanotech Security Corp.

“Doug H. Blakeway”
President and CEO

Source: http://nanosecurity.ca/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.